- Home
- NXPL vs CRIS Comparison
NXPL vs CRIS Comparison
Compare NXPL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- CRIS
- Stock Information
- Founded
- NXPL 1997
- CRIS 2000
- Country
- NXPL United States
- CRIS United States
- Employees
- NXPL N/A
- CRIS N/A
- Industry
- NXPL Telecommunications Equipment
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXPL Telecommunications
- CRIS Health Care
- Exchange
- NXPL Nasdaq
- CRIS Nasdaq
- Market Cap
- NXPL 17.9M
- CRIS 21.3M
- IPO Year
- NXPL N/A
- CRIS 2000
- Fundamental
- Price
- NXPL $0.77
- CRIS $1.81
- Analyst Decision
- NXPL
- CRIS Strong Buy
- Analyst Count
- NXPL 0
- CRIS 2
- Target Price
- NXPL N/A
- CRIS $16.50
- AVG Volume (30 Days)
- NXPL 32.6K
- CRIS 137.6K
- Earning Date
- NXPL 08-13-2025
- CRIS 07-31-2025
- Dividend Yield
- NXPL N/A
- CRIS N/A
- EPS Growth
- NXPL N/A
- CRIS N/A
- EPS
- NXPL N/A
- CRIS N/A
- Revenue
- NXPL $62,515,000.00
- CRIS $11,202,000.00
- Revenue This Year
- NXPL N/A
- CRIS N/A
- Revenue Next Year
- NXPL N/A
- CRIS $10.67
- P/E Ratio
- NXPL N/A
- CRIS N/A
- Revenue Growth
- NXPL 19.36
- CRIS 14.17
- 52 Week Low
- NXPL $0.43
- CRIS $1.02
- 52 Week High
- NXPL $2.30
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- NXPL 62.83
- CRIS 36.90
- Support Level
- NXPL $0.68
- CRIS $1.50
- Resistance Level
- NXPL $0.85
- CRIS $2.48
- Average True Range (ATR)
- NXPL 0.07
- CRIS 0.21
- MACD
- NXPL 0.00
- CRIS -0.07
- Stochastic Oscillator
- NXPL 61.74
- CRIS 25.20
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.